Regular ArticlesMice Deficient for the Type II Transmembrane Serine Protease, TMPRSS1/hepsin, Exhibit Profound Hearing Loss
Cited by (0)
Supported by Swiss National Science Foundation grant 3100A0-114077-1 (to M.G.), a Garnett Passe and Rodney Williams Memorial Foundation Research Training Fellowship (to M.G.), and a project grant (to M.G. and H.S.S.); by National Health and Medical Research Council (NHMRC) fellowships 171601 and 461204, NHMRC grants (project no. 215305 and program no. 257501), and the Nossal Leadership Award from the Walter and Eliza Hall Institute (to H.S.S.); and by the National Institute on Deafness and Other Communication Disorders (grant NO1-DC-3-1005), a Medical Research and Technology grant (Victoria, Australia), and the Marion and E.H. Flack Trust (to J.T.).
M.G. and J.T. contributed equally to this work.
Supplemental material for this article can be found on http://ajp.amjpathol.org.
Current address of M.G.: Division of Medical Genetics, University Hospital of Geneva, Geneva, Switzerland.
Current address of Q.W.: Molecular Cardiology/Nephrology & Hypertension Learner Research, Institute/ND50, The Cleveland Clinic Foundation, Cleveland, Ohio.